ARCHIVES

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

This article is from The Cancer Letter archive.

Vol. 04 No. 17 | April 28, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Approves Implant For Breast Reconstruction

July 26, 2013

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

No Issue Next Week

August 22, 1980

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011